Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson’s disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study

著录项

• 来源
  《Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology》 |2017年第2017期|共2页
• 作者

  N. Hattori; A. Takeda; S. Takeda; A. Nishimura; T. Kitagawa; H. Mochizuki; M. Nagai; R. Takahashi;

  展开▼
• 作者单位

  Juntendo University Faculty of Medicine Department of Neurology;

  National Hospital Organization Sendai Nishitaga Hospital Department of Neurology;

  Takeda Pharmaceutical Company Limited Japan Development Center;

  Takeda Pharmaceutical Company Limited Japan Development Center;

  Takeda Pharmaceutical Company Limited Japan Development Center;

  Osaka University Graduate School of Medicine Department of Neurology;

  Ehime University Hospital Clinical Therapeutic Trial Center;

  Kyoto University Graduate School of Medicine Department of Neurology;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 神经病学;
• 关键词